Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: Role of Homer 1a

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 1, 2010, Pages 40-45

  Guo, Wan Gang ^a,c   Su, Fei Fei ^a   Yuan, Li Jun ^a   Yang, Guo Dong ^c   Shi, Xiao Qin ^b   Li, Ruo Yu ^a   Shu, Qing ^c   Liu, Xiong Tao ^a   Lu, Zi Fan ^c   Zheng, Qiang Sun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular signal regulated kinases; Homer 1a; Hypertrophy

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; COMPLEMENTARY DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN HOMER 1A; SIMVASTATIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ANTICHOLESTEREMIC AGENTS; CARDIOMEGALY; CARRIER PROTEINS; CELL LINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIMVASTATIN; TRANSFECTION; UP-REGULATION;

EID: 74049164230     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05221.x     Document Type: Article

References (30)

1. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N. Engl. J. Med. 1987 317 : 787 792.
2. Manyari DE. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med. 1990 323 : 1706 1707.
3. Bueno OF, Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 2002 91 : 776 781.
4. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways. Cardiovasc. Res. 2000 47 : 23 37.
5. Aoki H, Richmond M, Izumo S, Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 2000 347 : 275 284.
6. Dechend R, Fiebeler A, Park JK et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation. 2001 104 : 576 581.
7. Liao JK. Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 2002 110 : 285 288.
8. Luo JD, Chen AF. Perspectives on the cardioprotective effects of statins. Curr. Med. Chem. 2003 10 : 1593 1601.
9. Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin. Exp. Pharmacol. Physiol. 1999 26 : 903 908.
10. Patel R, Nagueh SF, Tsybouleva N et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001 104 : 317 324.
11. Brakeman PR, Lanahan AA, O'Brien R et al. Homer: A protein that selectively binds metabotropic glutamate receptors. Nature 1997 386 : 284 288.
12. Tappe A, Klugmann M, Luo C et al. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat. Med. 2006 12 : 677 681.
13. Duncan RS, Hwang SY, Koulen P. Effects of Vesl/Homer proteins on intracellular signaling. Exp. Biol. Med. 2005 230 : 527 535.
14. Soloviev MM, Ciruela F, Chan WY, McIlhinney RA. Mouse brain and muscle tissues constitutively express high levels of Homer proteins. Eur. J. Biochem. 2000 267 : 634 639.
15. Sandona D, Tibaldo E, Volpe P. Evidence for the presence of two homer 1 transcripts in skeletal and cardiac muscles. Biochem. Biophys. Res. Commun. 2000 279 : 348 353.
16. Kawamoto T, Togi K, Yamauchi R et al. Endothelin-1 activates Homer 1alpha expression via mitogen-activated protein kinase in cardiac myocytes. Int. J. Mol. Med. 2006 18 : 193 196.
17. Guo WG, Yu ZB, Xie MJ. Protein kinase Cdelta is possibly involved in the transition from hypertrophy to apoptosis of myocardiocytes. Acta Physiol. Sin. 2006 58 : 269 274.
18. Gervásio OL, Whitehead NP, Yeung EW, Phillips WD, Allen DG. TRPC1 binds to caveolin-3 and is regulated by Src kinase-role in Duchenne muscular dystrophy. J. Cell Sci. 2008 121 : 2246 2255.
19. Hwang GS, Oh KS, Koo HN, Seo HW, You KH, Lee BH. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. Eur. J. Pharmacol. 2006 540 : 131 138.
20. Brostrom MA, Reilly BA, Wilson FJ, Brostrom CO. Vasopressin-induced hypertrophy in H9c2 heart-derived myocytes. Int. J. Biochem. Cell Biol. 2000 32 : 993 1006.
21. Huang WD, Fei Z, Zhang X. Traumatic injury induced homer-1a gene expression in cultured cortical neurons of rat. Neurosci. Lett. 2005 389 : 46 50.
22. Tan SJ, Pan JY, Zhan CY, Zhu XN. Effect of angiotensin II on c-fos expression and protein synthesis in cultured rat myocardial cells. Sheng Li Xue Bao 1999 51 : 521 526 (in Chinese with an English abstract).
23. Zhang GG, Zhang SD. Effect of simvastatin on cardiac fibrosis in patients with essential hypertension. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005 30 : 280 282 (in Chinese with an English abstract).
24. Wu L, Zhao L, Zheng Q et al. Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes. Mol. Cell. Biochem. 2006 284 : 65 71.
25. Satoh K, Shirota F, Tsunajima T, Beinlich CJ, Morgan HE, Ichihara K. Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: Comparison with pravastatin. Am. J. Physiol. Heart Circ. Physiol. 2001 280 : H2746 51.
26. Lebeche D, Kaprielian R, Hajjar R. Modulation of action potential duration on myocyte hypertrophic pathways. J. Mol. Cell. Cardiol. 2006 40 : 725 735.
27. Zhang SQ, Ding B, Guo ZG, Li YX. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte. Acta Pharmacol. Sin. 2004 25 : 41 6.
28. Mooradian AD, Haas MJ, Batejko O, Hovsepyan M, Feman SS. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 2005 54 : 2977 2982.
29. Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc. Res. 2004 61 : 745 755.
30. Tsai CT, Lai LP, Kuo KT et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: Implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008 117 : 344 355.